COMPANY

Licensure & Certifications

COMPANY

Licensure & Certifications

New York Clinical Laboratory Permit

NY Permit: 8613

Pennsylvania Laboratory Permit

PE Permit: 30909

Rhode Island Clinical Laboratory Permit

RI Permit: LCO01164

Maryland State Medical Laboratory Permit

MS Permit: 1453

CLIA Certificate

CL ID: 05D1078819

California Clinical Laboratory License

CA ID: CDF 336024

CAP Certificate

CA ID: 7199699

CAP Accreditation ISO

CA ID: 15189

DAkkS ISO

DA ID: 15189

DAkkS Accredited Activities

DAkkS Akkreditierte Aktivitäten

Quality Management System

QU ID: 13485

JAB ISO

JA ID: 15189

CAP Certificate

CA ID: 9234248

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Browse our comprehensive menu of product & testing services.

Myeloma

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing

Evaluation of Next-Generation Sequencing Versus Next-Generation Flow Cytometry for Minimal Residual Disease Detection in Chinese Patients with Multiple Myeloma

Lymphoma

Browse our comprehensive menu of product & testing services.

Myeloma

COMPANY

Licensure & Certifications

COMPANY